FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

American Health Packaging Metoprolol Succinate Extended-Release Tablets Recall

Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, Rx Only, Ma…

American Health Packaging · Columbus, OH

Risk level
Class II
Reported by FDA
Feb 2, 2022
Recall ID
D-0451-2022
Check your lot numberHow we source this data

Summary

American Health Packaging recalled Metoprolol Succinate Extended-Release Tablets starting Dec 20, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0451-2022 on Feb 2, 2022. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA. NDC 68001-501-03

Lot numbers, UPCs & expiration codes

Lots# 21141983, 21141984 and 21141985, Exp 03/31/2023; Lots# 21142017, 21142018, 21142019, Exp 02/28/2023

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0451-2022
Classification
Class II
Status
Terminated
Recall initiated
Dec 20, 2021
FDA report date
Feb 2, 2022
Quantity
6,637 500-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
American Health Packaging

Original FDA data

Every field from FDA enforcement report D-0451-2022, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
89377
Address
2550 John Glenn Ave Ste A
Code information
Lots# 21141983, 21141984 and 21141985, Exp 03/31/2023; Lots# 21142017, 21142018, 21142019, Exp 02/28/2023
Postal code
43217-1188
Report date
Feb 2, 2022
Product type
Drugs
Recall number
D-0451-2022
Classification
Class II
Recalling firm
American Health Packaging
Product quantity
6,637 500-count bottles
Termination date
Mar 9, 2023
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA. NDC 68001-501-03
Distribution pattern
Nationwide in the USA
Recall initiation date
Dec 20, 2021
Initial firm notification
Letter
Center classification date
Jan 25, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0451-2022, published Feb 2, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls